Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro Diagnostics

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1785846

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1785846

Biopsy Guidance Systems

PUBLISHED:
PAGES: 273 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Biopsy Guidance Systems Market to Reach US$1.4 Billion by 2030

The global market for Biopsy Guidance Systems estimated at US$1.1 Billion in the year 2024, is expected to reach US$1.4 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Stereotactic Guided Biopsy, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$825.2 Million by the end of the analysis period. Growth in the Ultrasound Guided Biopsy segment is estimated at 4.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$294.9 Million While China is Forecast to Grow at 8.7% CAGR

The Biopsy Guidance Systems market in the U.S. is estimated at US$294.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$300.1 Million by the year 2030 trailing a CAGR of 8.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.9% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Biopsy Guidance Systems Market - Key Trends & Drivers Summarized

Why Are Biopsy Guidance Systems Becoming Essential in Modern Diagnostics?

Biopsy guidance systems have become an indispensable tool in modern medical diagnostics, enabling greater accuracy, efficiency, and minimally invasive procedures for tissue sampling. These systems use advanced imaging technologies, including ultrasound, MRI, CT scans, and robotic-assisted navigation, to guide needle biopsies with precision. As the global burden of cancer and other chronic diseases continues to rise, the demand for highly accurate biopsy techniques has surged, making biopsy guidance systems crucial for early detection, treatment planning, and disease monitoring.

The shift toward minimally invasive procedures is further driving the adoption of biopsy guidance systems, as they reduce patient discomfort, lower complication rates, and enhance procedural efficiency. Additionally, the integration of artificial intelligence (AI) and real-time imaging in these systems is improving diagnostic accuracy and physician confidence. With the growing emphasis on personalized medicine and targeted therapies, biopsy guidance systems are playing a critical role in providing high-quality tissue samples necessary for molecular and genetic profiling. As healthcare providers prioritize early detection and precision diagnostics, the market for biopsy guidance systems is expected to expand significantly in the coming years.

How Are Technological Advancements Improving Biopsy Guidance Systems?

Technological innovations in imaging, robotics, and AI are transforming biopsy guidance systems, making them more precise, efficient, and user-friendly. One of the most significant advancements is the integration of AI-powered image recognition and real-time analytics, which help radiologists and surgeons identify optimal biopsy sites with greater accuracy. AI-enhanced biopsy systems can analyze imaging data in real time, providing automated recommendations for needle placement and reducing the risk of false-negative results. Additionally, 3D imaging and augmented reality (AR) overlays are enhancing visualization capabilities, allowing clinicians to navigate complex anatomical structures with unprecedented clarity.

Another breakthrough in biopsy guidance technology is the development of robotic-assisted biopsy systems, which provide superior needle control, stability, and automation. These systems minimize human error and allow for more precise targeting of small or difficult-to-reach lesions. Additionally, advancements in elastography and contrast-enhanced ultrasound are improving soft tissue differentiation, enabling better detection of malignant tumors in dense tissue environments. Wireless and portable biopsy guidance systems are also gaining traction, offering greater flexibility for use in outpatient settings and remote healthcare facilities. As these technological innovations continue to evolve, biopsy guidance systems are becoming increasingly efficient, accurate, and accessible to a broader range of healthcare providers.

Which Market Trends Are Driving the Growth of Biopsy Guidance Systems?

The increasing global incidence of cancer and other chronic diseases is one of the most significant trends driving the biopsy guidance systems market. With cancer rates rising worldwide, early and accurate diagnosis has become a primary focus for healthcare providers, leading to greater adoption of advanced biopsy guidance technologies. Additionally, the growing popularity of image-guided minimally invasive procedures is accelerating demand for systems that offer high precision with minimal patient discomfort. As a result, MRI-guided and ultrasound-guided biopsy systems are gaining widespread acceptance in oncology, breast imaging, and interventional radiology.

Another key trend shaping the market is the expansion of AI-driven healthcare solutions. AI-assisted biopsy guidance is improving workflow efficiency, reducing biopsy procedure times, and minimizing operator dependency, making these systems more accessible to a wider range of medical professionals. Furthermore, the rise of liquid biopsy and molecular diagnostics is complementing traditional tissue biopsies, leading to the development of hybrid biopsy guidance solutions that integrate imaging with biomarker detection. The increasing adoption of telemedicine and remote diagnostics is also fueling demand for portable and cloud-connected biopsy guidance systems, enabling real-time consultation and remote expert guidance for complex cases.

What Are the Key Growth Drivers Shaping the Future of the Biopsy Guidance Systems Market?

The growth in the biopsy guidance systems market is driven by several key factors, including rising cancer prevalence, advancements in imaging technology, and increasing investments in precision medicine. One of the primary growth drivers is the growing emphasis on early cancer detection and diagnosis, which has led to increased screening programs and diagnostic procedures. Governments and healthcare organizations worldwide are implementing cancer awareness initiatives, further driving the adoption of advanced biopsy guidance systems to improve diagnostic accuracy.

Another crucial driver shaping the market is the integration of AI and robotics in biopsy procedures. AI-driven decision support tools are enabling faster and more accurate diagnoses, while robotic-assisted systems are improving biopsy precision and reducing procedure-related complications. Additionally, the growing demand for outpatient and ambulatory care services is driving the need for compact, portable, and cost-effective biopsy guidance systems. As healthcare providers seek to enhance diagnostic efficiency while minimizing patient discomfort, the adoption of advanced biopsy guidance systems is expected to accelerate, positioning them as a critical tool in the future of precision medicine and cancer diagnostics.

SCOPE OF STUDY:

The report analyzes the Biopsy Guidance Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Stereotactic Guided Biopsy, Ultrasound Guided Biopsy, MRI Guided Biopsy); Application (Brain Biopsy Application, Breast Biopsy Application, Other Applications); End-Use (Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use, Research and Academic Institutes End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 39 Featured) -

  • Argon Medical Devices, Inc.
  • Becton, Dickinson and Company (BD)
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Medical, LLC
  • Hologic, Inc.
  • INRAD, Inc.
  • Mammotome
  • PAJUNK(R) GmbH
  • Planmed Oy
  • Siemens Healthineers AG
  • Trivitron Healthcare

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP29608

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Biopsy Guidance Systems - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Burden of Cancer and Chronic Diseases Throws the Spotlight on Biopsy Guidance Systems for Accurate Diagnostics
    • Surge in Demand for Minimally Invasive Procedures Drives Adoption of Image-Guided Biopsy Technologies
    • Technological Advancements in Imaging Modalities Strengthen the Business Case for Real-Time Biopsy Guidance Systems
    • Shift Toward Early and Precision Diagnosis Expands Addressable Market Opportunity for Targeted Biopsy Devices
    • Integration of Ultrasound, CT, MRI, and Fusion Imaging Enhances Accuracy and Outcomes of Biopsy Procedures
    • Increasing Preference for Outpatient and Ambulatory Biopsy Settings Fuels Demand for Portable and User-Friendly Guidance Systems
    • Growth in Interventional Radiology and Image-Guided Oncology Spurs Wider Adoption of Navigation and Targeting Technologies
    • AI-Powered Imaging and Software-Driven Needle Guidance Systems Propel Innovation in Biopsy Procedures
    • Rising Demand for Organ-Specific and Site-Specific Biopsy Solutions Drives Market Segmentation and Customization
    • Improved Patient Comfort and Procedural Efficiency Strengthen the Shift from Manual to Automated Biopsy Guidance Systems
    • Advancements in Robotics and 3D Navigation Technologies Enhance Precision and Reduce Human Error in Biopsy Procedures
    • Increasing Adoption of Real-Time Tissue Characterization and Elastography Supports Intelligent Biopsy Targeting
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Biopsy Guidance Systems Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Biopsy Guidance Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Stereotactic Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Stereotactic Guided Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Ultrasound Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Ultrasound Guided Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for MRI Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for MRI Guided Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Research and Academic Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Research and Academic Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Brain Biopsy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Brain Biopsy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Breast Biopsy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Breast Biopsy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 24: USA Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • CANADA
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • JAPAN
    • Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • CHINA
    • Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 42: China Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • EUROPE
    • Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Biopsy Guidance Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • FRANCE
    • Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • GERMANY
    • Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • UNITED KINGDOM
    • Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 82: Spain Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Spain 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 84: Spain Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Spain 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 88: Russia Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Russia 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 90: Russia Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Russia 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 94: Rest of Europe Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of Europe 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 96: Rest of Europe Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of Europe 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific 6-Year Perspective for Biopsy Guidance Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2025 & 2030
    • TABLE 100: Asia-Pacific Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Asia-Pacific 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 102: Asia-Pacific Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Asia-Pacific 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • AUSTRALIA
    • Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 106: Australia Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Australia 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 108: Australia Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Australia 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • INDIA
    • Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 112: India Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: India 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 114: India Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: India 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • SOUTH KOREA
    • TABLE 118: South Korea Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: South Korea 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 120: South Korea Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: South Korea 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 124: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of Asia-Pacific 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 126: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • LATIN AMERICA
    • Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 130: Latin America Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 131: Latin America 6-Year Perspective for Biopsy Guidance Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2025 & 2030
    • TABLE 132: Latin America Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Latin America 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 136: Latin America Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 137: Latin America 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • ARGENTINA
    • TABLE 138: Argentina Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 139: Argentina 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 142: Argentina Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 143: Argentina 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • BRAZIL
    • TABLE 144: Brazil Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 145: Brazil 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 148: Brazil Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 149: Brazil 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • MEXICO
    • TABLE 150: Mexico Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 151: Mexico 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 154: Mexico Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 155: Mexico 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 156: Rest of Latin America Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 157: Rest of Latin America 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 160: Rest of Latin America Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 161: Rest of Latin America 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • MIDDLE EAST
    • Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 162: Middle East Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 163: Middle East 6-Year Perspective for Biopsy Guidance Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 166: Middle East Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 167: Middle East 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 168: Middle East Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 169: Middle East 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 172: Iran Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 173: Iran 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 174: Iran Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 175: Iran 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 178: Israel Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 179: Israel 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 180: Israel Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 181: Israel 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 184: Saudi Arabia Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 185: Saudi Arabia 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 186: Saudi Arabia Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 187: Saudi Arabia 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 190: UAE Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 191: UAE 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 192: UAE Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 193: UAE 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 196: Rest of Middle East Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 197: Rest of Middle East 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 198: Rest of Middle East Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 199: Rest of Middle East 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • AFRICA
    • Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 202: Africa Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 203: Africa 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 204: Africa Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 205: Africa 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!